Low-cost air quality portable sensors and their potential use in respiratory health by Sesé, L., Gille, T., Pau, G., Dessimond, B., Uzunhan, Y., Bouvry, D., Hervé, A., Didier, M., Kort, F., Freynet, O., Rotenberg, C., Jeny, F., Khamis, W., Hindre, R., Maesano, C. N., Planes, C., Nunes, H., Annesi-Maesano, I.

Get full text

Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients by Daccord, C, Cottin, V, Prévot, G, Uzunhan, Y, Mornex, J F, Bonniaud, P, Borie, R, Briault, A, Collonge-Rame, M A, Crestani, B, Devouassoux, G, Freynet, O, Gondouin, A, Hauss, P A, Khouatra, C, Leroy, S, Marchand-Adam, S, Marquette, C, Montani, D, Naccache, J M, Nadeau, G, Poulalhon, N, Reynaud-Gaubert, M, Salaun, M, Wallaert, B, Cordier, J F, Faouzi, M, Lazor, R

Get full text

Two-year follow-up of 196 interstitial lung disease patients after ICU stay by Tandjaoui-Lambiotte, Y., Gonzalez, F., Boubaya, M., Freynet, O., Clec´h, C., Bonnet, N., Van Der Meersch, G., Oziel, J., Huang, C., Uzunhan, Y., Brillet, P-Y., Poirson, F., Martin, O., Ahmed, P., Ebstein, N., Karoubi, P., Gaudry, S., Nunes, H., Cohen, Y.

Get full text

Treatment of sarcoidosis by Londner, C, Zendah, I, Freynet, O, Carton, Z, Dion, G, Nunes, H, Valeyre, D

Get full text

Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis by Lanternier, F, Poiree, S, Elie, C, Garcia-Hermoso, D, Bakouboula, P, Sitbon, K, Herbrecht, R, Wolff, M, Ribaud, P, Lortholary, O

Get full text

Dupilumab : une alternative à la corticothérapie pour l’Adult onset Asthma and PeriOcular Xanthogranuloma syndrome (AAPOXs) ? by Finet, F., Sese, L., Soussan, M., Uzunhan, Y., Freynet, O., Dhôte, R., Abad, S.

Get full text

A40 CONNECTIVE TISSUE DISEASE RELATED INTERSTITIAL LUNG DISEASE: RISK FACTORS, DIAGNOSIS, AND OUTCOMES: Prognosis Of Interstitial Lung Disease In Myositis by Obert, J, Freynet, O, Nunes, H, Brillet, P, Dhote, R, Valeyre, D, Naccache, J

Get full text

Traitement de la sarcoïdose by Londner, C., Zendah, I., Freynet, O., Carton, Z., Dion, G., Nunes, H., Valeyre, D.

Get full text

Traitement de la sarcoïdose : Sarcoïdose by LONDNER, C, ZENDAH, I, FREYNET, O, CARTON, Z, DION, G, NUNES, H, VALEYRE, D

Get full text

Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/my... by Bardet, Valérie, Wagner-Ballon, Orianne, Guy, Julien, Morvan, Céline, Debord, Camille, Trimoreau, Franck, Benayoun, Emmanuel, Chapuis, Nicolas, Freynet, Nicolas, Rossi, Cédric, Mathis, Stéphanie, Gourin, Marie-Pierre, Toma, Andréa, Béné, Marie C, Feuillard, Jean, Guérin, Estelle

Get full text

Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study by Jestin, Matthieu, Tarfi, Sihem, Duchmann, Matthieu, Badaoui, Bouchra, Freynet, Nicolas, Tran Quang, Violaine, Sloma, Ivan, Droin, Nathalie, Morabito, Margot, Leclerc, Mathieu, Maury, Sébastien, Fenaux, Pierre, Solary, Eric, Selimoglu-Buet, Dorothée, Wagner-Ballon, Orianne

Get full text

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: TET2 MUTATIONAL STATUS AFFECTS MYELODYSPLASTIC SYNDROME EVOLUTION TO CHRONIC MYELOMONOCYTIC LEUKEMIA by Quang, V. Tran, Podvin, B., Desterke, C., Tarfi, S., Barathon, Q., Bouchra, B., Freynet, N., Parinet, V., Leclerc, M., Sébastien, M., Solary, E., Selimoglu-Buet, D., Duployez, N., Wagner-Ballon, O., Sloma, I.

Get full text